omeprazole has been researched along with Leukopenia in 1 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Leukopenia: A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000).
Excerpt | Relevance | Reference |
---|---|---|
"We present here a clinical history and an in vitro test of cytotoxicity linking leukopenia to omeprazole." | 7.70 | Omeprazole-induced leukopenia. A case report. ( Brunet, C; Dehee, D; Dine, T; Gressier, B; Luyckx, MM; Martin, P; Membré, S; Moulron, S; Odou, P; Tamiji, L, 1999) |
"We present here a clinical history and an in vitro test of cytotoxicity linking leukopenia to omeprazole." | 3.70 | Omeprazole-induced leukopenia. A case report. ( Brunet, C; Dehee, D; Dine, T; Gressier, B; Luyckx, MM; Martin, P; Membré, S; Moulron, S; Odou, P; Tamiji, L, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Odou, P | 1 |
Martin, P | 1 |
Membré, S | 1 |
Gressier, B | 1 |
Tamiji, L | 1 |
Dine, T | 1 |
Luyckx, MM | 1 |
Brunet, C | 1 |
Dehee, D | 1 |
Moulron, S | 1 |
1 other study available for omeprazole and Leukopenia
Article | Year |
---|---|
Omeprazole-induced leukopenia. A case report.
Topics: Adult; Anti-Ulcer Agents; Female; Humans; Leukopenia; Omeprazole | 1999 |